JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by van Montfoort, J. E.
Right arrow Articles by Meier, P. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by van Montfoort, J. E.
Right arrow Articles by Meier, P. J.

Vol. 298, Issue 1, 110-115, July 2001

Comparison of "Type I" and "Type II" Organic Cation Transport by Organic Cation Transporters and Organic Anion-Transporting Polypeptides

Jessica E. van Montfoort, Michael Müller, Geny M. M. Groothuis, Dirk K. F. Meijer, Hermann Koepsell and Peter J. Meier

Division of Clinical Pharmacology and Toxicology, Department of Medicine, University Hospital, Zürich, Switzerland (J.E.v.M., P.J.M.); Department of Pharmacokinetics and Drug Delivery, Groningen University Institute for Drug Exploration, Groningen, The Netherlands (J.E.v.M., G.M.M.G., D.K.F.M.); Sub-department of Human Nutrition and Epidemiology, Nutrition, Metabolism, and Genomics Group, Wageningen University and Research Center, Wageningen, The Netherlands (M.M.); and Department of Anatomy, University of Würzburg, Würzburg, Germany (H.K.)

Previous inhibition studies with taurocholate and cardiac glycosides suggested the presence of separate uptake systems for small "type I" (system1) and for bulky "type II" (system2) organic cations in rat hepatocytes. To identify the transport systems involved in type I and type II organic cation uptake, we compared the organic cation transport properties of the rat and human organic cation transporter 1 (rOCT1; hOCT1) and of the organic anion-transporting polypeptides 2 and A (rat Oatp2; human OATP-A) in cRNA-injected Xenopus laevis oocytes. Based on characteristic cis-inhibition patterns of rOCT1-mediated tributylmethylammonium and Oatp2-mediated rocuronium uptake, rOCT1 and Oatp2 could be identified as the organic cation uptake systems1 and 2, respectively, in rat liver. While hOCT1 exhibited similar transport properties as rOCT1, OATP-A- but not Oatp2-mediated rocuronium uptake was inhibited by the OATP-A substrate N-methyl-quinidine. The latter substrate was also transported by rOCT1 and hOCT1, demonstrating distinct organic cation transport activities for rOCT1 and Oatp2 and overlapping organic cation transport activities for hOCT1 and OATP-A. Finally, the data demonstrate that unmethylated quinidine is transported by rOCT1, hOCT1, and OATP-A at pH 6.0, but not at pH 7.5, indicating that quinidine requires a positive charge for carrier-mediated uptake into hepatocytes. In conclusion, the studies demonstrate that in rat liver the suggested organic cation uptake systems1 and 2 correspond to rOCT1 and Oatp2, respectively. However, the rat-based type I and II organic cation transporter classification cannot be extended without modification from rat to human.

0022-3565/01/2981-0110$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 2001 by The American Society for Pharmacology and Experimental Therapeutics


This article has been cited by other articles:


Home page
 J. Pharmacol. Exp. Ther.Home page
A. Libra, C. Fernetti, V. Lorusso, M. Visigalli, P. L. Anelli, F. Staud, C. Tiribelli, and L. Pascolo
Molecular Determinants in the Transport of a Bile Acid-Derived Diagnostic Agent in Tumoral and Nontumoral Cell Lines of Human Liver
J. Pharmacol. Exp. Ther., November 1, 2006; 319(2): 809 - 817.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
W. M. Suhre, S. Ekins, C. Chang, P. W. Swaan, and S. H. Wright
Molecular Determinants of Substrate/Inhibitor Binding to the Human and Rabbit Renal Organic Cation Transporters hOCT2 and rbOCT2
Mol. Pharmacol., April 1, 2005; 67(4): 1067 - 1077.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. Rev.Home page
S. H. Wright and W. H. Dantzler
Molecular and Cellular Physiology of Renal Organic Cation and Anion Transport
Physiol Rev, July 1, 2004; 84(3): 987 - 1049.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
J. W. Jonker and A. H. Schinkel
Pharmacological and Physiological Functions of the Polyspecific Organic Cation Transporters: OCT1, 2, and 3 (SLC22A1-3)
J. Pharmacol. Exp. Ther., January 1, 2004; 308(1): 2 - 9.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
C. Volk, V. Gorboulev, T. Budiman, G. Nagel, and H. Koepsell
Different Affinities of Inhibitors to the Outwardly and Inwardly Directed Substrate Binding Site of Organic Cation Transporter 2
Mol. Pharmacol., November 1, 2003; 64(5): 1037 - 1047.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
D. Bednarczyk, S. Ekins, J. H. Wikel, and S. H. Wright
Influence of Molecular Structure on Substrate Binding to the Human Organic Cation Transporter, hOCT1
Mol. Pharmacol., March 1, 2003; 63(3): 489 - 498.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
K. B. Goralski, G. Lou, M. T. Prowse, V. Gorboulev, C. Volk, H. Koepsell, and D. S. Sitar
The Cation Transporters rOCT1 and rOCT2 Interact with Bicarbonate but Play Only a Minor Role for Amantadine Uptake into Rat Renal Proximal Tubules
J. Pharmacol. Exp. Ther., December 1, 2002; 303(3): 959 - 968.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
O. Briz, M. A. Serrano, N. Rebollo, B. Hagenbuch, P. J. Meier, H. Koepsell, and J. J.G. Marin
Carriers Involved in Targeting the Cytostatic Bile Acid-Cisplatin Derivatives cis-Diammine-chloro-cholylglycinate-platinum(II) and cis-Diammine-bisursodeoxycholate-platinum(II) toward Liver Cells
Mol. Pharmacol., April 1, 2002; 61(4): 853 - 860.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
P. Arndt, C. Volk, V. Gorboulev, T. Budiman, C. Popp, I. Ulzheimer-Teuber, A. Akhoundova, S. Koppatz, E. Bamberg, G. Nagel, et al.
Interaction of cations, anions, and weak base quinine with rat renal cation transporter rOCT2 compared with rOCT1
Am J Physiol Renal Physiol, September 1, 2001; 281(3): F454 - F468.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 2001 by the American Society for Pharmacology and Experimental Therapeutics.